drugset
drugset / Trial / NCT05180591

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

NCT05180591 ↗

Phase 2 Active not recruiting 150 enrolled Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate if repeat bacillus Calmette-Guérin (BCG) vaccinations can confer a beneficial immune and metabolic effect on pediatric Type 1 diabetes.

Timeline

Start
2022-03-22
Primary completion
2031-03
Completion
2031-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacillus Calmette-Guérin Vaccine — —

Indications

diabetes mellitus, congenital autoimmune type 1 diabetes mellitus